多囊卵巢综合征与脂类代谢异常

被引:2
作者
杨星
梁晓燕
机构
[1] 中山大学第一医院妇产科
关键词
多囊卵巢综合征; 脂类代谢异常; 治疗;
D O I
暂无
中图分类号
R711.75 [卵巢疾病]; R589 [代谢病];
学科分类号
100211 ; 1002 ; 100201 ;
摘要
多囊卵巢综合患者(PCOS)可出现不同程度的脂类代谢异常,主要与肥胖、高胰岛素血症、高雄激素血症等因素密切相关,治疗方面需要在调整生活方式的基础之上,利用药物减少胰岛素抵抗,降低高雄激素血症。
引用
收藏
页码:8 / 10
页数:3
相关论文
共 12 条
[1]   Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels [J].
Panidis, Dimitrios ;
Farmakiotis, Dimitrios ;
Rousso, David ;
Kourtis, Anargyros ;
Katsikis, Flias ;
Krassas, Gerassimos .
FERTILITY AND STERILITY, 2008, 89 (04) :899-906
[2]   A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: A case-control study [J].
Valkenburg, Olivier ;
Steegers-Theunissen, Regine P. M. ;
Smedts, Huberdina P. M. ;
Dallinga-Thie, Geesje M. ;
Fauser, Bart C. J. M. ;
Westerveld, Egbertine H. ;
Laven, Joop S. E. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (02) :470-476
[3]   Rosiglitazone decreases 11β-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue [J].
Mai, Knut ;
Andres, Janin ;
Bobbert, Thomas ;
Maser-Gluth, Christiane ;
Moehlig, Matthias ;
Baehr, Volker ;
Pfeiffer, Andreas F. H. ;
Spranger, Joachim ;
Diederich, Sven .
CLINICAL ENDOCRINOLOGY, 2007, 67 (03) :419-425
[4]  
Peroxisome Proliferator-Activated Receptor γ and Adipose Tissue-Understanding Obesity-Related Changes in Regulation of Lipid and Glucose Metabolism.[J].Arya M. Sharma;Bart Staels.The Journal of Clinical Endocrinology & Metabolism.2007, 2
[5]   Effects of simvastatin and oral contraceptive agent on polycystic ovary syndrome: Prospective, randomized, crossover trial [J].
Banaszewska, Beata ;
Pawelczyk, Leszek ;
Spaczynski, Robert Z. ;
Dziura, James ;
Duleba, Antoni J. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (02) :456-461
[6]   Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: A randomized, 12-month, placebo-controlled study [J].
Gambineri, Alessandra ;
Patton, Laura ;
Vaccina, Antonella ;
Cacciari, Mauro ;
Morselli-Labate, Antonio Maria ;
Cavazza, Carla ;
Pagotto, Uberto ;
Pasquali, Renato .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (10) :3970-3980
[7]  
Mevastatin inhibits proliferation of rat ovarian theca–interstitial cells by blocking the mitogen-activated protein kinase pathway.[J].Jakub Kwintkiewicz;Nastaran Foyouzi;Piotr Piotrowski;Izabela Rzepczynska;Antoni J. Duleba.Fertility and Sterility.2006, 4
[8]   Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome [J].
Lo, JC ;
Feigenbaum, SL ;
Yang, JR ;
Pressman, AR ;
Selby, JV ;
Go, AS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (04) :1357-1363
[9]   Orlistat is as beneficial as metformin in the treatment of polycystic ovarian syndrome [J].
Jayagopal, V ;
Kilpatrick, ES ;
Holding, S ;
Jennings, PE ;
Atkin, SL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (02) :729-733
[10]   Sibutramine has a positive effect on clinical and metabolic parameters in obese patients with polycystic ovary syndrome [J].
Sabuncu, T ;
Harma, M ;
Harma, M ;
Nazligul, Y ;
Kilic, F .
FERTILITY AND STERILITY, 2003, 80 (05) :1199-1204